T1	Participants 470 482	200 patients
T2	Participants 386 460	patients with moderately severe poisoning from organophosphorus pesticides
T3	Participants 1396 1448	Patients receiving the high-dose pralidoxime regimen
T4	Participants 1292 1340	100 patients were assigned the high-dose regimen
T5	Participants 1346 1369	100 the control regimen
